GLTO Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 11.90%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Galecto Insider Trading History Chart

Galecto Share Price & Price History

^$7.40

▲ +0.13 (1.79%)

As of 10/28/2024 12:10 PM ET

Days: 30 | 90 | 365

Central banks prepare for America’s Breaking Point

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.

Galecto Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/31/2023	Orbimed Advisors Llc	Major Shareholder	Sell	8,376	$75.00	$628,200.00	5,421
7/25/2023	Orbimed Advisors Llc	Major Shareholder	Sell	1,568	$73.00	$114,464.00	6,486
7/13/2023	Orbimed Advisors Llc	Major Shareholder	Sell	7,788	$60.00	$467,280.00	6,798
4/17/2023	Orbimed Advisors Llc	Major Shareholder	Sell	523	$49.25	$25,757.75	7,190
4/14/2023	Orbimed Advisors Llc	Major Shareholder	Sell	1,657	$46.50	$77,050.50	7,216
4/12/2023	Orbimed Advisors Llc	Major Shareholder	Sell	94	$45.25	$4,253.50	7,328
4/10/2023	Orbimed Advisors Llc	Major Shareholder	Sell	2,049	$44.75	$91,692.75	7,436
4/5/2023	Orbimed Advisors Llc	Major Shareholder	Sell	3,718	$54.50	$202,631.00	7,484
3/22/2022	Bertil Lindmark	Insider	Buy	584	$54.00	$31,536.00
3/22/2022	Hans T. Schambye	CEO	Buy	200	$53.75	$10,750.00
12/3/2021	Garrett Winslow	General Counsel	Buy	80	$62.00	$4,960.00
12/3/2021	Jonathan Freve	CFO	Buy	160	$62.25	$9,960.00
11/9/2021	Hans T. Schambye	CEO	Buy	180	$87.50	$15,750.00
11/8/2021	Jonathan Freve	CFO	Buy	120	$85.00	$10,200.00

Nvidia is Pivoting to Solve Big Tech’s $1 Trillion Problem

From Weiss Ratings | Ad

Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …

Find out details on these three critical Nvidia partners immediately.

SEC Filings (Institutional Ownership Changes) for Galecto (NASDAQ:GLTO)

14.20% of Galecto stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Galecto Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
10/24/2024	Novo Holdings A S	99,913	$1.21M	0.1%	-96.0%	0.369%
11/15/2023	Laurion Capital Management LP	88,580	$64K	0.0%	-53.5%	0.327%
8/8/2023	Belvedere Trading LLC	15,037	$38K	0.0%	N/A	0.055%
8/4/2023	Simplex Trading LLC	11,399	$28K	0.0%	+3,699.7%	0.042%
8/2/2023	MAI Capital Management	245,281	$0.62M	0.0%	-4.0%	0.956%
7/10/2023	Trust Co. of Toledo NA OH	22,432	$57K	0.0%	+86.9%	0.087%
5/10/2023	MAI Capital Management	255,453	$0.51M	0.0%	+9.5%	0.995%
2/9/2023	MAI Capital Management	233,283	$0.27M	0.0%	-31.2%	0.912%
9/16/2022	Federated Hermes Inc.	40,000	$69K	0.0%	+53.8%	0.158%
7/19/2022	MAI Capital Management	320,860	$0.56M	0.0%	N/A	1.270%
7/15/2022	Marquette Asset Management LLC	60,244	$0.10M	0.0%	+31.6%	0.238%
4/26/2022	Marquette Asset Management LLC	45,765	$0.10M	0.0%	+25.4%	0.181%
1/19/2022	Marquette Asset Management LLC	36,500	$0.11M	0.0%	+51.2%	0.144%
11/16/2021	Janus Henderson Group PLC	1,286,007	$4.50M	0.0%	-1.0%	5.091%
11/16/2021	Migdal Insurance & Financial Holdings Ltd.	10,400	$37K	0.0%	N/A	0.041%
11/16/2021	Two Sigma Advisers LP	243,500	$0.87M	0.0%	N/A	0.964%
11/16/2021	Two Sigma Investments LP	152,353	$0.55M	0.0%	N/A	0.603%
11/16/2021	Laurion Capital Management LP	194,852	$0.70M	0.0%	-6.1%	0.771%
11/12/2021	Renaissance Technologies LLC	102,900	$0.37M	0.0%	+159.2%	0.407%
10/12/2021	Marquette Asset Management LLC	24,135	$87K	0.0%	N/A	0.096%
9/17/2021	Virtu Financial LLC	12,867	$65K	0.0%	N/A	0.051%
8/17/2021	Maverick Capital Ltd.	356,309	$1.80M	0.0%	-26.2%	1.410%
8/17/2021	Bridgeway Capital Management LLC	208,100	$1.05M	0.0%	N/A	0.824%
8/16/2021	Tudor Investment Corp Et Al	54,100	$0.27M	0.0%	-6.7%	0.214%
8/16/2021	Federated Hermes Inc.	12,000	$61K	0.0%	-40.0%	0.048%
8/13/2021	Renaissance Technologies LLC	39,700	$0.20M	0.0%	N/A	0.157%
8/13/2021	Blueshift Asset Management LLC	25,238	$0.13M	0.0%	N/A	0.100%
8/13/2021	Geode Capital Management LLC	74,720	$0.38M	0.0%	N/A	0.296%
8/13/2021	Vanguard Group Inc.	24,546	$0.12M	0.0%	N/A	0.097%
8/12/2021	XTX Topco Ltd	11,018	$56K	0.0%	N/A	0.044%
7/31/2021	Asymmetry Capital Management L.P.	60,968	$0.31M	0.2%	-46.3%	0.241%
5/18/2021	Millennium Management LLC	82,850	$0.50M	0.0%	+18.3%	0.328%
5/18/2021	Maverick Capital Ltd.	482,672	$2.90M	0.0%	-1.6%	1.911%
5/18/2021	Tudor Investment Corp Et Al	57,957	$0.35M	0.0%	-10.0%	0.229%
5/17/2021	Janus Henderson Group PLC	1,321,929	$7.83M	0.0%	-1.0%	5.233%
5/17/2021	Sphera Funds Management LTD.	448,016	$2.72M	0.2%	+14.4%	1.773%
5/17/2021	Goldman Sachs Group Inc.	13,397	$81K	0.0%	N/A	0.053%
5/14/2021	Weiss Multi Strategy Advisers LLC	16,154	$98K	0.0%	-60.7%	0.064%
5/11/2021	Asymmetry Capital Management L.P.	113,515	$0.69M	0.4%	-66.4%	0.449%
5/7/2021	BlackRock Inc.	538,896	$3.27M	0.0%	-17.7%	2.133%
2/16/2021	Orbimed Advisors LLC	4,090,937	$51.18M	0.4%	N/A	16.195%
2/16/2021	Tudor Investment Corp Et Al	64,415	$0.81M	0.0%	N/A	0.255%
2/16/2021	Janus Henderson Group PLC	1,335,569	$15.86M	0.0%	N/A	5.287%
2/12/2021	Caas Capital Management LP	20,000	$0.25M	0.0%	N/A	0.079%
2/12/2021	Laurion Capital Management LP	207,552	$2.59M	0.0%	N/A	0.822%
2/12/2021	Federated Hermes Inc.	20,000	$0.25M	0.0%	N/A	0.079%
2/11/2021	Asymmetry Capital Management L.P.	337,352	$4.22M	1.9%	N/A	1.335%
2/11/2021	Monashee Investment Management LLC	84,163	$1.05M	0.1%	N/A	0.333%
2/5/2021	BlackRock Inc.	654,870	$8.19M	0.0%	N/A	2.592%

Data available starting January 2016

Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB2064, a selective oral small molecule inhibitor of LOXL2 that is in Phase 2a clinical trial for the treatment of fibrotic diseases, including cancer and myelofibrosis; and GB1211, a selective oral galectin-3 inhibitor that is in Phase IIa for the treatment of cancer, as well as in Phase Ib/IIa for fibrosis. Galecto, Inc. was founded in 2011 and is headquartered in Copenhagen, Denmark.

Today's Range

Now: $7.40

$7.34

$7.40

50 Day Range

MA: $10.73

$0.48

$14.88

52 Week Range

Now: $7.40

$6.50

$23.50

Volume

3,945 shs

Average Volume

16,464 shs

Market Capitalization

$8.07 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.16

Who are the company insiders with the largest holdings of Galecto?: Galecto's top insider shareholders include:
Orbimed Advisors Llc (Major Shareholder)
Learn More about top insider investors at Galecto.
Who are the major institutional investors of Galecto?: Galecto's top institutional shareholders include:
Novo Holdings A S — 0.37%
Learn More about top institutional investors of Galecto stock.
Which institutional investors are selling Galecto stock?: In the last quarter, GLTO stock was sold by these institutional investors:
Novo Holdings A S